GB1446341A - 15-substituted-omega-pentanorprostaglandins - Google Patents

15-substituted-omega-pentanorprostaglandins

Info

Publication number
GB1446341A
GB1446341A GB3121773A GB3121773A GB1446341A GB 1446341 A GB1446341 A GB 1446341A GB 3121773 A GB3121773 A GB 3121773A GB 3121773 A GB3121773 A GB 3121773A GB 1446341 A GB1446341 A GB 1446341A
Authority
GB
United Kingdom
Prior art keywords
tetranor
thienyl
oxo
trans
pentanorprostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3121773A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to GB1355676A priority Critical patent/GB1446342A/en
Priority to GB1444976A priority patent/GB1446344A/en
Priority to GB1420176A priority patent/GB1446343A/en
Publication of GB1446341A publication Critical patent/GB1446341A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

1446341 Silylated prostaglandins PFIZER Inc 13 July 1973 [13 July 1972] 31217/73 Heading C3S [Also in Division C2] 11α,15α - Bis - (dimethylisopropylsilyloxy)- 9 - oxo - 16 - (2 - thienyl) - 17,18,19,20 - tetranor - trans - 13 - prostenoic acid is prepared by hydrogenating 11α,15α - bis - (dimethylisopropylsilyloxy) - 9 - oxo - 16 - (2 - thienyl)- 17,18,19,20 - tetranor - cis - 5, trans - 13- prostadienoic acid, obtained by reacting dimethylisopropyl chlorosilane with 11α,15α- dihydroxy - 9 - oxo - 16 - (2 - thienyl) - 17,18, 19,20 - tetranor - cis - 5 trans - 13 - prostadienoic acid.
GB3121773A 1972-07-13 1973-07-13 15-substituted-omega-pentanorprostaglandins Expired GB1446341A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB1355676A GB1446342A (en) 1972-07-13 1973-07-13 Substituted alkyl phosphonate diesters
GB1444976A GB1446344A (en) 1972-07-13 1973-07-13 Bis-tetrahydropyranyl-ethers
GB1420176A GB1446343A (en) 1972-07-13 1973-07-13 Cyclopenta-6-furan derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
GB1446341A true GB1446341A (en) 1976-08-18

Family

ID=23034697

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3121773A Expired GB1446341A (en) 1972-07-13 1973-07-13 15-substituted-omega-pentanorprostaglandins

Country Status (25)

Country Link
JP (4) JPS5241257B2 (en)
AR (2) AR209064A1 (en)
AT (1) AT367033B (en)
BE (1) BE802231A (en)
CA (1) CA1041495A (en)
CH (1) CH593254A5 (en)
CS (1) CS201027B2 (en)
DD (2) DD116459A5 (en)
DE (1) DE2334945A1 (en)
ES (4) ES416865A1 (en)
FI (1) FI57583C (en)
FR (1) FR2192834B1 (en)
GB (1) GB1446341A (en)
HU (4) HU171158B (en)
IE (1) IE37909B1 (en)
IL (2) IL42691A (en)
IN (1) IN138789B (en)
LU (1) LU68015A1 (en)
NL (1) NL7309792A (en)
NO (2) NO143741C (en)
PH (1) PH11461A (en)
SE (3) SE7705946L (en)
SU (4) SU644384A3 (en)
YU (1) YU187773A (en)
ZA (1) ZA734769B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2149788A (en) * 1983-11-04 1985-06-19 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins and process for their preparation
US6310087B2 (en) * 1992-09-21 2001-10-30 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2463432C2 (en) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
DE2416193C2 (en) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin analogs, processes for their preparation and their use as cytoprotective agents
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
SE9002596D0 (en) * 1990-08-08 1990-08-08 Pharmacia Ab A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES
KR100578616B1 (en) * 2004-07-23 2006-05-10 한미약품 주식회사 Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose
CN105814033B (en) * 2013-12-13 2019-10-25 阿勒根公司 The solid form and its preparation and application of the substitution dihydroxy cyclopentanone-based compounds of α, ω bis-

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2149788A (en) * 1983-11-04 1985-06-19 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins and process for their preparation
US4585791A (en) * 1983-11-04 1986-04-29 Farmitalia Carlo Erba, S.P.A. Furyl derivatives of 16-substituted prostaglandins
US6310087B2 (en) * 1992-09-21 2001-10-30 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Also Published As

Publication number Publication date
FR2192834B1 (en) 1979-04-06
SU584791A3 (en) 1977-12-15
DE2334945A1 (en) 1974-03-07
SU644384A3 (en) 1979-01-25
FI57583C (en) 1980-09-10
AR209064A1 (en) 1977-03-31
HU171156B (en) 1977-11-28
NO144830B (en) 1981-08-10
NL7309792A (en) 1974-01-15
AT367033B (en) 1982-05-25
IL42691A0 (en) 1973-10-25
IL50308A0 (en) 1976-10-31
PH11461A (en) 1978-02-01
HU171158B (en) 1977-11-28
NO144830C (en) 1981-11-18
IE37909L (en) 1974-01-13
FI57583B (en) 1980-05-30
HU171946B (en) 1978-04-28
IN138789B (en) 1976-04-03
JPS5297958A (en) 1977-08-17
SE7705945L (en) 1977-05-20
JPS52122349A (en) 1977-10-14
BE802231A (en) 1974-01-14
CS201027B2 (en) 1980-10-31
JPS5293753A (en) 1977-08-06
JPS4992053A (en) 1974-09-03
ZA734769B (en) 1974-06-26
ES437038A1 (en) 1977-01-01
SU645564A3 (en) 1979-01-30
DD116459A5 (en) 1975-11-20
LU68015A1 (en) 1974-01-21
IL42691A (en) 1979-07-25
NO143741C (en) 1981-04-08
NO743492L (en) 1974-01-15
SU645563A3 (en) 1979-01-30
ATA620773A (en) 1981-10-15
YU187773A (en) 1982-02-25
SE7705946L (en) 1977-05-20
JPS5241257B2 (en) 1977-10-17
HU172058B (en) 1978-05-28
CA1041495A (en) 1978-10-31
ES416865A1 (en) 1976-03-01
FR2192834A1 (en) 1974-02-15
ES437039A1 (en) 1977-01-01
SE7705947L (en) 1977-05-20
NO143741B (en) 1980-12-29
AR214383A1 (en) 1979-06-15
AU5778473A (en) 1975-01-09
ES437037A1 (en) 1977-01-01
IE37909B1 (en) 1977-11-09
CH593254A5 (en) 1977-11-30
DD109210A5 (en) 1974-10-20

Similar Documents

Publication Publication Date Title
GB1409841A (en) Prostaglandins and the manufacture thereof
GB1448413A (en) Prostaglandins and the manufacture therof
GB1471312A (en) Mining installation
GB1456512A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
GB1456838A (en) 16,17,18,19,20-pentanorprostaglandins
ZA744509B (en) Prostanoic acid derivatives
GB1446341A (en) 15-substituted-omega-pentanorprostaglandins
ES419143A1 (en) Prostanoic acid derivatives
GB1369185A (en) Process for the production of fructose
CA945414A (en) Running feedback adjustment of envelope making machines
CA1028699A (en) Prostanoic acid derivatives
AU502576B2 (en) 11-deoxy prostaglandins
GB1494940A (en) Process for the preparation of an octadienenitrile compound
ES399014A1 (en) (r)-1-(2-furoyloxy)-3-methylbutyl-pencillin compounds
GB1328747A (en) Preparation of n-1-ethyl-2-pyrrolidinyl-methyl-2-methoxy-5- sulphamoyl-benzamide
GB1411065A (en) Prostaglandin compounds
GB1377036A (en) Process for the manufacture of a cast floor covering based on anhydrite
GB1535994A (en) Deuterated prostaglandin analogues
GB1494939A (en) 3,7-dimethyl-3-hydroxy-6-octenenitrile and process for its preparation
CA983924A (en) Process for preparing derivatives of prostanoic acid, homologs thereof, and intermediates therefor
GB1415212A (en) Trioxatricycloundecane derivatives and process for their manufacture
GB1461440A (en) 2,5-substituted tetrahydrofurans and their production
CA983874A (en) Process for producing adenosine-3',5'-cyclic monophosphoric acid by fermentation
GB1413831A (en) Prostatrienoic acid derivatives and process
ES430294A1 (en) Fast, brown sulfur dyestuffs and process for the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee